Serum S-100B is superior to neuron-specific enolase as an early prognostic biomarker for neurological outcome following cardiopulmonary resuscitation
- 18 June 2009
- journal article
- research article
- Published by Elsevier in Resuscitation
- Vol. 80 (8) , 870-875
- https://doi.org/10.1016/j.resuscitation.2009.05.005
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Education, Culture, Sports, Science and Technology
This publication has 31 references indexed in Scilit:
- Prediction of cognitive dysfunction after resuscitation from out-of-hospital cardiac arrest using serum neuron-specific enolase and protein S-100Heart, 2007
- Cardiac Arrest Resuscitation Evaluation in Los Angeles: CARE-LAAnnals of Emergency Medicine, 2005
- Outcome after cardiac arrest: predictive values and limitations of the neuroproteins neuron-specific enolase and protein S-100 and the Glasgow Coma ScaleResuscitation, 2005
- S100B Protein in Clinical Diagnostics: Assay SpecificityClinical Chemistry, 2004
- Serum Neuron-Specific Enolase and S-100B Protein in Cardiac Arrest Patients Treated With HypothermiaStroke, 2003
- Mild Therapeutic Hypothermia to Improve the Neurologic Outcome after Cardiac ArrestNew England Journal of Medicine, 2002
- Time Course of Serum Neuron-Specific EnolaseStroke, 1999
- Increased Serum Levels of the S-100 Protein Are Associated With Hypoxic Brain Damage After Cardiac ArrestStroke, 1998
- Recommended guidelines for reviewing, reporting, and conducting research on in-hospital resuscitation: the in-hospital ‘Utstein style’Resuscitation, 1997
- Neuron Specific Enolase, A Clinically Useful Marker for Neurons and Neuroendocrine CellsAnnual Review of Neuroscience, 1987